Mulder, N H <br/><br/>
Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.  [electronic resource] 

 -  British journal of cancer  Oct 1994 
 - 681-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1994.372  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Combined Modality Therapy<br/>Dacarbazine--administration & dosage<br/>Dactinomycin--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Immunotherapy<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Treatment Outcome<br/>Vinblastine--administration & dosage